Prospective study demonstrates improved survival prediction from combining performance status and mGPS in advanced lung cancer, highlighting enhanced clinical assessment.
Performance status and the mGPS are superior prognostic factors in advanced lung cancer. In combination, these improved survival prediction compared with either alone.
No takes yet. Share an insight, caveat, or question.
Simmons et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: